Pfizer said Sunday that it was buying the rights to a somewhat controversial cell therapy from Athersys, a biotechnology company — a sign of big pharmaceutical companies’ growing interest in stem cells.
Pfizer will have the rights to develop Athersys’s cells to treat inflammatory bowel disease, the companies are expected to announce on Monday. It will pay Athersys $6 million initially and up to $105 million in the future.
read more: http://www.nytimes.com/2009/12/21/business/21pfizer.html
Incoming search terms:
stemgenex reviews, stemgenex complaints, stemgenex cost, cos of treatment with stem genex, stemgenex fraud, stem genex complaints, complaings on stem genex, stem genex fraud, stem genex, is stemgenex a hoax, www stem-cells-news com/1/2012/03/pfizer, athersys fraud, stem genex reviews, athersys fruad, stemgenex/cancer, what does stemgenex charge for stem cell treatment of copd?, stemgenex review before and after, stemgenex review, stemgenex patient complaints, stemgenex complaints scam, StemGenex clinics, pfizer acquires athersys inc, newcells by pfizer, complaints stenGenex, big pharms on stem cell thearphy/ patients reviews?, www stemrenex com.
